Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver

References

• Aleksunes LM, Scheffer GL, Jakowski AB, et al. (2006). Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. Toxicol Sci 89:370–9
   PubMed Web of Science ®Google Scholar
• Chen T, Zhang L, Yue JQ, et al. (2012). Prenatal PFOS exposure induces oxidative stress and apoptosis in the lung of rat off-spring. Reprod Toxicol 33:538–45
   PubMed Web of Science ®Google Scholar
• Corsini A, Bortolini M. (2013). Drug-induced liver injury: The role of drug metabolism and transport. J Clin Pharmacol 53:463–74
   PubMed Web of Science ®Google Scholar
• Dong Y, Huang J, Lin X, et al. (2014). Hepatoprotective effects of yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice. J Ethnopharmacol 152:201–6
   PubMed Web of Science ®Google Scholar
• Du H, Chen X, Fang Y, et al. (2013). Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: A meta-analysis. Mol Biol Rep 40:3591–6
   PubMed Web of Science ®Google Scholar
• Fu Y, Hsieh TC, Guo J, et al. (2004). Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 322:263–70
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. (2012). Nuclear receptor control of enterohepatic circulation. Compr Physiol 2:2811–28
   PubMed Web of Science ®Google Scholar
• Jatav SK, Kulshrestha A, Zacharia A, et al. (2014). Spirulina maxima protects liver from isoniazid and rifampicin drug toxicity. J Evid Based Complementary Altern Med 19:189–94
   PubMedGoogle Scholar
• Knodell RG, Ishak KG, Black WC, et al. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–5
   PubMed Web of Science ®Google Scholar
• Koga K, Kawashima S, Shibata N, Takada K. (2007). Novel formulations of a liver protection drug glycyrrhizin. Yakugaku Zasshi 127:1103–14
   PubMed Web of Science ®Google Scholar
• Morimoto R, Hayashi M, Yatsushiro S, et al. (2003). Co-expression of vesicular glutamate transporters (VGLUT1 and VGLUT2) and their association with synaptic-like microvesicles in rat pinealocytes. J Neurochem 84:382–91
   PubMed Web of Science ®Google Scholar
• Pal R, Vaiphei K, Sikander A, et al. (2006). Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats. World J Gastroenterol 12:636–9
   PubMed Web of Science ®Google Scholar
• Paulusma CC, Van Geer MA, Evers R, et al. (1999). Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338:393–401
   PubMed Web of Science ®Google Scholar
• Reichel C, Gao B, Van Montfoort J, et al. (1999). Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology 117:688–95
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. (2006). Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241–59
   PubMed Web of Science ®Google Scholar
• Saad EI, El-Gowilly SM, Sherhaa MO, Bistawroos AE. (2010). Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats. Food Chem Toxicol 48:1869–75
   PubMed Web of Science ®Google Scholar
• Santhosh S, Sini TK, Anandan R, Mathew PT. (2006). Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. Toxicology 219:53–9
   PubMed Web of Science ®Google Scholar
• Santhosh S, Sini TK, Anandan R, Mathew PT. (2007). Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. Eur J Pharmacol 572:69–73
   PubMed Web of Science ®Google Scholar
• Schuetz JD, Swaan PW, Tweedie DJ. (2014). The role of transporters in toxicity and disease. Drug Metab Dispos 42:541–5
   PubMed Web of Science ®Google Scholar
• Statti GA, Tundis R, Sacchetti G, et al. (2004). Variability in the content of active constituents and biological activity of Glycyrrhiza glabra. Fitoterapia 75:371–4
   PubMed Web of Science ®Google Scholar
• Tirona RG, Leake BF, Podust LM, Kim RB. (2004). Identification of amino acids in rat pregnane X receptor that determine species-specific activation. Mol Pharmacol 65:36–44
   PubMed Web of Science ®Google Scholar
• Tirona RG, Leake BF, Wolkoff AW, Kim RB. (2003). Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 304:223–8
   PubMed Web of Science ®Google Scholar
• Tostmann A, Boeree MJ, Aarnoutse RE, et al. (2008). Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J Gastroenterol Hepatol 23:192–202
   PubMed Web of Science ®Google Scholar
• Van Staden CJ, Morgang RE, Ramachandran B, et al. (2012). Membrane vesicle ABC transporter assays for drug safety assessment. Curr Protoc Toxicol doi: 10.1002/0471140856.tx2305s54. Chapter 23, Unit 23 5
   PubMedGoogle Scholar
• Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. (2002). Interactions of rifampicin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 36:164–72
   PubMed Web of Science ®Google Scholar
• Wolf KK, Vora S, Webster LO, et al. (2010). Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport. Toxicol In Vitro 24:297–309
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang X, Yang J, et al. (2012). Effects of glycyrrhizin on biliary transport and hepatic levels of glutathione in rats. Biopharm Drug Dispos 33:235–45
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang GQ, Wei YH, et al. (2013). The impact of drug transporters on adverse drug reaction. Eur J Drug Metab Pharmacokinet 38:77–85
   PubMed Web of Science ®Google Scholar
• Zhu MT, Feng WY, Wang B, et al. (2008). Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology 247:102–11
   PubMed Web of Science ®Google Scholar